Delayed graft function continues to pose a significant challenge to clinicians in the context of kidney transplantation. The objective of this retrospective, 5-year analysis is to identify the parameters of beating heart donors and those of recipients that affect the delayed development of graft function. The monitored group was composed of 152 beating heart donors and 179 recipients. Delayed graft function was identified in 32 (17%) patients. The predictor for development of delayed graft function was the body mass index of the donor (odds ratio: 
Introduction
Delayed graft function (DGF) continues to pose a significant challenge to clinicians in the context of kidney transplantation. Based on the current trends, kidneys from expanded criteria or cardiac death donors will continue to expand, which will increase the prevalence of DGF in the immediate postoperative setting. 1 The incidence of DGF depends on its definition, on the risk profiles of the donor and the recipient, 2 and on the definition used within the transplant center. The most widespread and most easily calculated definition of DGF is dialysis in the first week after surgery and should be generally accepted as the clinical definition of DGF and as a study end point. 3 As DGF is a major obstacle to allograft life, it can be compounded by acute rejection and chronic allograft nephropathy. 4 Many donor-specific risk factors for DGF in renal transplantation have been identified, including both immunologic (eg, absence of T-cell antibody induction therapy, female donor gender) and nonimmunologic (donor age, weight, prolonged cold/warm ischemia time) origin. 5 There is no information about the body mass index (BMI) of beating heart donors as a risk factor for delayed graft function in the available literature. Small analyses describe the effect on graft survival in the case of a donor BMI of more than 45 kg/m 2 .
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Materials and Methods
This is a retrospective study, and the objective of our 5-year analysis is to identify the beating heart donor and recipient parameters that affect the onset of graft function. All procedures performed in studies involving human participants are approved with the ethical standards of the institutional and/ or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. In the group of Caucasian deceased beating heart donors, where kidneys were procured for transplantation in the years 2003 to 2014 in the Martin Transplant Center, we analyzed the following: age at the time of death, sex, cause of death, alcohol intake (according to the donor's family and documentation), type of donor (expanded criteria donor [ECD]/standard criteria donor), presence of arterial hypertension and diabetes mellitus in donor's history values of creatinine, the estimated glomerular filtration (eGFR, by the CKD-EPI formula), concentrations of minerals in the blood before collection (sodium, potassium, and chlorides), BMI, and presence of proteinuria before organ collection. Alcohol intake was categorized as abuse if there was daily consumption of alcohol.
In kidney recipients, the following variables were collected: age at the time of kidney transplantation, sex, onset of graft function (primary or delayed onset of function-the necessity of dialysis treatment a week or more after kidney transplantation), BMI, type of induction, type of immunosuppression (tacrolimus, cyclosporine A, and mammalian target of rapamycin (mTOR) inhibitor), the duration of cold ischemia, presence of postoperative complications within 30 days after transplantation (lymphocele, stricture of the ureter, and bleeding with necessity of revision), presence of acute rejection within 12 months after transplantation or presence of rejection in the later posttransplantation period (after the 12th month following transplantation), and graft function (by creatinine and eGFR) on the seventh posttransplantation day, 1, 3, and 6 months after transplantation, and also 1, 3, and 5 years after transplantation. In the case of DGF, we performed a kidney biopsy within 7 days after kidney transplantation.
A donor with extended criteria means a donor per the definition of ECD codified in 2002: donors over the age of 60 years without comorbidities or donors over the age of 50 years with at least 2 comorbidities that include blood hypertension, death from cerebrovascular accident, or terminal serum creatinine levels >1.5 mg/dL. 7 The statistical program MedCalc version 13.1.2 (MedCalc Software's VAT registration number is BE 0809 344 640, Member of International Association of Statistical Computing, Ostend, Belgium) was used for statistical evaluation and we used the following statistical analyses: Student t test, w 2 test, correlation coefficient, Kaplan-Meier curves, logistic regression, and Cox regression analysis. We considered values of P < .05 to indicate statistical significance.
Results
In the years 2003 to 2014, 152 kidney procurement was performed in the Martin Transplant Center from deceased donors with beating hearts and an average age of 46 years (standard deviation [SD] ¼ 16) (range, 1-72 years) at the time of death. During this time, 179 kidneys were transplanted from the donors. The average age of the recipients at the time of transplantation was 46.8 (SD ¼ 11.4) years (15-68 years). In our group, we identified 32 (18.9%) patients with DGF (see Table 1 ).
As shown in Table 1 , recipients with DGF underwent kidney transplantation from statistically significantly older donors with significantly higher BMI values, and significantly more donors had abuse of ethyl alcohol in their history. The most frequent cause of DGF was acute tubular necrosis (98%).
Independent risk factors for delayed graft function in our group were a donor BMI of more than 30 kg/m 2 and abuse of alcohol in the donor's history ( Table 2 ). The occurrence of delayed graft function was correlated with the donor's age and BMI.
The survival of both patients and grafts (by Kaplan-Meier curves) was worse in cases of patients with delayed graft function (both the 12-month survival and 5-year survival), although no statistically significant difference in survival was recorded.
Discussion
Delayed graft function remains a vexing complication of kidney transplantation with detrimental effects on both graft life and patient survival. Over the past decade, a consensus definition has developed to provide greater clarity in the study of DGF. Research into the molecular mechanisms of oxidant stress, vasospasm, cytokine signaling, endothelial cell injury, epithelial cell injury, innate immunity, and adaptive immunity have improved our understanding of DGF. The complexity of pathologic mechanisms that cause DGF offers many potential targets for therapy to inhibit oxidant stress, encourage vasodilation, and blunt the immune response.
In our group, we identified a donor BMI of greater than 30 kg/m 2 as an independent risk factor for DGF, and the occurrence of DGF correlated with the BMI value of the donor. In a prospective analysis by the American authors, Jin et al, who monitored the onset of graft function in the case of a graft from a donor with a BMI less than 35 kg/m 2 versus donors with a BMI more than 35 kg/m 2 , did not confirm the donor BMI as a risk factor for DGF (21.4% vs 20.0%; P ¼ not significant). However, the donors in that study were nonbeating heart donors. 7 The Registry of Transplant Recipients data on recipients of deceased donor kidneys between 1997 and 2010 were reviewed by Ortiz et al. The primary outcome, death-censored graft life, was adjusted for donor, recipient, and transplant characteristics. Among recipients of non-donor after cardiac death (DCD) kidneys, donor BMI was not associated with DGF. Among DCD recipients, donor BMI was not associated with DGF for donor BMI categories <45 kg/m 2 ; however, donor BMI 45 kg/m 2 was independently associated with DGF compared with BMI of 20 to 24.9 kg/m 2 (adjusted hazard ratio [HR]: 1.84; 95% confidence interval: 1.23-2.74). The adjusted odds ratio of DGF was greater for each level of BMI above the reference for both DCD and non-DCD groups. Although BMI was associated with DGF, long-term graft life was not affected except in the combination of DCD with extreme donor BMI 45. We hypothesize that the donor BMI and donor's perirenal fat tissue affect the onset of graft function specifically due to worse conditions in collection and extended collection of organs in cases of donor's obesity. Macroscopic findings on kidneys from obese donors are worse compared to nonobese donors due to the perirenal fat and atherosclerotic changes in renal arteria, which may also contribute to the development of DGF in recipients.
In our group of patients, we further identified abuse of alcohol by the donor as an independent risk factor for DGF. We hypothesized that donors who are alcohol drinkers tend to develop hypotension and hypovolemia.
The results of a single-center study by Lin et al show that the donor's history of cigarette smoking is a statistically significant risk factor for both graft life (HR ¼ 1.05; P < .05) and recipient survival (HR ¼ 1.06; P < .05), whereas neither intravenous drug use nor alcohol dependency had a significant adverse impact on graft or recipient survival. 8 We assumed that donors who abused alcohol were also smokers, which may support the risk factor for DGF, as in the mentioned analysis. However, additional studies and monitoring of donor abuse of alcohol and donor BMI as risk factors for DGF must be confirmed by more extensive prospective analyses.
Conclusion
Donor BMI and alcohol abuse represent a risk factor for delayed graft function. The occurrence of obese donors is constantly increasing, which relates to more and more collections from donors with BMI values of more than 30 or even more than 35 kg/m 2 . 9 In cases of accumulated risk factors for DGF (ECD, prolonged cold ischemia, etc) together with a higher BMI, it is appropriate to maintain an immunologic protocol with respect to possible development of DGF.
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